EA202190888A1 - Пептид для применения в косметике - Google Patents

Пептид для применения в косметике

Info

Publication number
EA202190888A1
EA202190888A1 EA202190888A EA202190888A EA202190888A1 EA 202190888 A1 EA202190888 A1 EA 202190888A1 EA 202190888 A EA202190888 A EA 202190888A EA 202190888 A EA202190888 A EA 202190888A EA 202190888 A1 EA202190888 A1 EA 202190888A1
Authority
EA
Eurasian Patent Office
Prior art keywords
peptide
cosmetic applications
photoaging
prevention
sequence
Prior art date
Application number
EA202190888A
Other languages
English (en)
Inventor
Пабло Пеллегрини
Original Assignee
Колоссиум Комбинаториал Кемистри Сентр Фо Текнолоджи Сосьета А Респонсабилита' Лимитата Ин Форма Аббревиата К4Т С.Р.Л.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Колоссиум Комбинаториал Кемистри Сентр Фо Текнолоджи Сосьета А Респонсабилита' Лимитата Ин Форма Аббревиата К4Т С.Р.Л. filed Critical Колоссиум Комбинаториал Кемистри Сентр Фо Текнолоджи Сосьета А Респонсабилита' Лимитата Ин Форма Аббревиата К4Т С.Р.Л.
Publication of EA202190888A1 publication Critical patent/EA202190888A1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8129—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by an alcohol, ether, aldehydo, ketonic, acetal or ketal radical; Compositions of hydrolysed polymers or esters of unsaturated alcohols with saturated carboxylic acids; Compositions of derivatives of such polymers, e.g. polyvinylmethylether
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/042—Gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37—Esters of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/73—Polysaccharides
    • A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Psychology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Настоящее изобретение относится к применению пептида, содержащего последовательность ID NO: 1, и его косметической композиции для лечения и предупреждения старения кожи и фотостарения.
EA202190888A 2018-10-11 2019-10-10 Пептид для применения в косметике EA202190888A1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT102018000009384A IT201800009384A1 (it) 2018-10-11 2018-10-11 Peptide for cosmetic application
PCT/IB2019/058641 WO2020075108A1 (en) 2018-10-11 2019-10-10 Peptides for use in treating and preventing skin aging and photo-aging

Publications (1)

Publication Number Publication Date
EA202190888A1 true EA202190888A1 (ru) 2021-07-07

Family

ID=65010824

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202190888A EA202190888A1 (ru) 2018-10-11 2019-10-10 Пептид для применения в косметике

Country Status (13)

Country Link
US (1) US20210395305A1 (ru)
EP (1) EP3863728A1 (ru)
JP (1) JP2022508676A (ru)
KR (1) KR20210075098A (ru)
CN (1) CN112823039A (ru)
AU (1) AU2019357261A1 (ru)
BR (1) BR112021006742A2 (ru)
CA (1) CA3115025A1 (ru)
EA (1) EA202190888A1 (ru)
IL (1) IL282064B (ru)
IT (1) IT201800009384A1 (ru)
SG (1) SG11202103026YA (ru)
WO (1) WO2020075108A1 (ru)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT202000020287A1 (it) * 2020-08-20 2022-02-20 Colosseum Combinatorial Chemistry Centre For Tech Societa A Responsabilita Limitata In Forma Abbrevi Peptide per applicazioni terapeutiche in campo dermatologico
KR20230046140A (ko) * 2021-09-29 2023-04-05 (주)케어젠 항노화 활성을 갖는 펩타이드 및 이의 용도
KR20230046141A (ko) * 2021-09-29 2023-04-05 (주)케어젠 항노화 활성을 갖는 펩타이드 및 이의 용도
KR20230046872A (ko) * 2021-09-30 2023-04-06 (주)케어젠 항노화 활성을 갖는 펩타이드 및 이의 용도
KR20230046873A (ko) * 2021-09-30 2023-04-06 (주)케어젠 항노화 활성을 갖는 펩타이드 및 이의 용도

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7196055B2 (en) 1994-08-31 2007-03-27 Trustees Of Boston University Inhibition of apoptosis in keratinocytes by a ligand of p75 nerve growth factor receptor
GB9616105D0 (en) * 1996-07-31 1996-09-11 Univ Kingston TrkA binding site of NGF
EP0977860A1 (en) * 1997-04-25 2000-02-09 Genentech, Inc. Ngf variants
US6919426B2 (en) 2002-09-19 2005-07-19 Amgen Inc. Peptides and related molecules that modulate nerve growth factor activity
MEP31508A (en) 2003-07-15 2010-10-10 Amgen Inc Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors
ME00226B (me) 2004-07-15 2011-02-10 Medarex Llc Humana anti-ngf neutrališuća antitijela kao selektivni inhibitori ngf signalne kaskade
KR101520333B1 (ko) * 2008-11-25 2015-05-14 (주)아모레퍼시픽 글루타밀아미도에틸 인돌을 함유하는 항노화용 화장료 조성물
SG183983A1 (en) 2010-03-17 2012-10-30 Abbott Res Bv Anti-nerve growth factor (ngf) antibody compositions
ITRM20110574A1 (it) * 2011-11-02 2013-05-03 Sampo S R L Preparato topico per indurre la pigmentazione cutanea e per il trattamento di discromie cutanee e vitiligine.
AU2016326434A1 (en) * 2015-09-22 2018-03-29 Johnson & Johnson Consumer Inc. Devices and methods for enhancing the topical application of a benefit agent
KR20170049299A (ko) * 2015-10-28 2017-05-10 경상대학교산학협력단 성장인자와 사이토카인을 포함하는 조성물
CN112409471B (zh) * 2016-04-13 2022-07-29 舒泰神（北京）生物制药股份有限公司 低痛神经生长因子突变体
CN107973848B (zh) * 2017-12-28 2020-10-16 未名生物医药有限公司 一种从混合物中分离天然序列神经生长因子的方法

Also Published As

Publication number Publication date
JP2022508676A (ja) 2022-01-19
IL282064B (en) 2022-09-01
SG11202103026YA (en) 2021-04-29
KR20210075098A (ko) 2021-06-22
CN112823039A (zh) 2021-05-18
US20210395305A1 (en) 2021-12-23
IL282064A (en) 2021-05-31
AU2019357261A1 (en) 2021-05-13
EP3863728A1 (en) 2021-08-18
BR112021006742A2 (pt) 2021-09-21
CA3115025A1 (en) 2020-04-16
WO2020075108A1 (en) 2020-04-16
IT201800009384A1 (it) 2020-04-11

Similar Documents

Publication Publication Date Title
EA202190888A1 (ru) Пептид для применения в косметике
EA201990298A1 (ru) Способы и композиции для лечения рака
EA202190960A1 (ru) Конденсированные пирролины, которые действуют как ингибиторы убиквитин-специфической протеазы 30 (usp30)
EA201800591A1 (ru) Микрокапсулы, содержащие живые микроорганизмы, и их применение
MX2019006515A (es) Composiciones que comprenden peptido wkdeagkplvk.
WO2015056216A3 (pt) Composição peptídica e respetivos usos
EA201891183A1 (ru) Композиции, содержащие натуральные экстракты, и их применение для кожи и волос
WO2019045248A3 (ko) 주름 개선 활성을 나타내는 펩타이드 및 이의 용도
MX2022015725A (es) Inhibidores peptidicos ciclicos de la proteina 95 de la densidad post-sinaptica (psd-95) y usos de los mismos.
EA202190310A1 (ru) Белок для лечения воспалительных заболеваний
EA202092820A1 (ru) Композиция для расслабления мышц
EA202191476A1 (ru) Гетероароматические соединения в качестве ингибиторов ванина
PH12020500029A1 (en) Cosmetic compositions and methods of use
ECSP20083339A (es) Proteínas inmunodominantes y fragmentos en esclerosis múltiple
EA201590601A1 (ru) Применение pedf-производных полипептидов для лечения остеоартрита
EA201790336A1 (ru) Антитела к ангиопоэтинподобному белку 4 и способы применения
PH12021550122A1 (en) Solubilized apyrases, methods and use
EA202191446A1 (ru) Композиции для улучшения сексуальной функции
BR112016026637A2 (pt) associação de um tetrapeptídeo e um gliceril éster para tratamento de alopecia androgênica
BR112019003816A2 (pt) composição de tratamento de enxágue dos cabelos, método para tratamento de cabelos quimicamente danificados e uso de uma composição
EA202090470A1 (ru) Композиция для личного ухода
EA202191758A1 (ru) Пептиды для лечения и профилактики диабета и связанных с ним заболеваний
EA201690966A1 (ru) Новое соединение для лечения тяжелой гипогликемии
EA202092045A1 (ru) Лечение и предупреждение преэклампсии
EA202092691A1 (ru) Соединения для устранения боли, композиции, содержащие их, и способы их применения